Do Caco-2 Subclones Provide More Appropriate in Vitro Models for Understanding how Human Enteric Pathogens Cause Disease?

Abstract

Future MicrobiologyVol. 8, No. 6 EditorialDo Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease?Brendan Kenny & Paul DeanBrendan Kenny* Author for correspondenceInstitute for Cell & Molecular Biosciences, Newcastle University, Medical School, Newcastle-upon-Tyne, NE2 4HH, UK. .Search for more papers by this authorEmail the corresponding author at brendan.kenny@ncl.ac.uk & Paul DeanInstitute for Cell & Molecular Biosciences, Newcastle University, Medical School, Newcastle-upon-Tyne, NE2 4HH, UKSearch for more papers by this authorPublished Online:23 May 2013https://doi.org/10.2217/fmb.13.51AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: Caco-2enteric pathogenenteropathogenic Escherichia coliEPECpolarized epitheliasubcloneTC7transfectionReferences1 Kaper JB, McDaniel TK, Jarvis KG, Gomez-Duarte O. Genetics of virulence of enteropathogenic E. coli. Adv. Exp. Med. Biol.412,279–287 (1997).Crossref, Medline, CAS, Google Scholar2 Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat. Rev. Microbiol.2,123–140 (2005).Crossref, Google Scholar3 Kenny B, Valdivia R. Host–microbe interactions: bacteria. Curr. Opin. Microbiol.12,1–3 (2009).Crossref, Medline, CAS, Google Scholar4 Turner JR. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol.9,799–809 (2009).Crossref, Medline, CAS, Google Scholar5 Sambuy Y, De Angelis I, Ranaldi G et al. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol.21,1–26 (2005).Crossref, Medline, CAS, Google Scholar6 Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics8,91 (2007).Crossref, Medline, Google Scholar7 Christensen J, El-Gebali S, Natoli M et al. Defining new criteria for selection of cell-based intestinal models using publicly available databases. BMC Genomics13,274 (2012).Crossref, Medline, Google Scholar8 Volpe DA. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Future Med. Chem.3,2063–2077 (2011).Crossref, Medline, CAS, Google Scholar9 Volpe DA. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J. Pharm. Sci.97,712–725 (2008).Crossref, Medline, CAS, Google Scholar10 Canil C, Rosenshine I, Ruschkowski S et al. Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infect. Immun.61,2755–2762 (1993).Crossref, Medline, CAS, Google Scholar11 Miyake M, Hanajima M, Matsuzawa T et al. Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli. Biochem. Biophys. Res. Commun.337,922–927 (2005).Crossref, Medline, CAS, Google Scholar12 Dean P, Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol.54,665–675 (2004).Crossref, Medline, CAS, Google Scholar13 Muza-Moons MM, Koutsouris A, Hecht G. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun.71,7069–7078 (2003).Crossref, Medline, CAS, Google Scholar14 Dean P, Muehlen S, Quitard S, Kenny B. The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-injected Tir effector. Cell. Microbiol.12,1308–1321 (2010).Crossref, Medline, CAS, Google Scholar15 Dean P, Maresca M, Schuller S, Phillips AD, Kenny B. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl Acad. Sci. USA103,1876–1881 (2006).Crossref, Medline, CAS, Google Scholar16 Ruchaud-Sparagano MH, Maresca M, Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol.9,1909–1921 (2007).Crossref, Medline, CAS, Google Scholar17 Gres MC, Julian B, Bourrie M, Meunier V et al. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res.15,726–733 (1998).Crossref, Medline, CAS, Google Scholar18 Dean P, Young L, Quitard S, Kenny B. Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte model. PLoS ONE 8, 12(9),1308–1321 (2013).Google ScholarFiguresReferencesRelatedDetails Vol. 8, No. 6 Follow us on social media for the latest updates Metrics Downloaded 53 times History Published online 23 May 2013 Published in print June 2013 Information© Future Medicine LtdKeywordsCaco-2enteric pathogenenteropathogenic Escherichia coliEPECpolarized epitheliasubcloneTC7transfectionFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download